T1	Participants 80 113	patients with cardiac syndrome-X.
T2	Participants 387 425	patients with cardiac syndrome-X (CSX)
T3	Participants 501 577	Thirty patients, 17 female and 13 male, with CSX were enrolled in the study.
T4	Participants 1409 1426	patients with CSX
